Antifungal susceptibilities of clinical and environmental isolates of Cryptococcus neoformans in Goiânia City, Goiás, Brazil

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 47, Issue 5, 2005, Pages 253-256

  Souza, Lúcia Kioko Hasimoto ^b   Fernandes, Orionalda De Fátima Lisboa ^a   Kobayashi, Cláudia Castelo Branco Artiaga ^a   Passos, Xisto Sena ^a   Costa, Carolina Rodrigues ^a   Lemos, Janine Aquino ^a   Souza Jr , Ary Henrique ^b   Silva, Maria Do Rosário Rodrigues ^a,c  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b PONTIFÍCIA UNIVERSIDADE CATÓLICA DE GOIÁS   (Brazil)

^c NONE   (Brazil)

Author keywords

Antifungal agents; Cerebrospinal fluid; Cryptococcus neoformans; Environment

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; ANTIFUNGAL AGENT; FLUCONAZOLE; ITRACONAZOLE; VORICONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC SENSITIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; BRAZIL; BROTH MICRODILUTION METHOD; CEREBROSPINAL FLUID; CRYPTOCOCCUS NEOFORMANS; DILUTION; EVALUATION; FUNGAL STRAIN; FUNGUS CULTURE; FUNGUS ISOLATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN;

EID: 27644591405     PISSN: 00364665     EISSN: 16789946     Source Type: Journal    
DOI: 10.1590/S0036-46652005000500003     Document Type: Article

References (27)

1. CASADEVALL, A. & PERFECT, J.R. - Cryptococcus neoformans. Washington, American Society for Microbiology, 1998.
2. CHANDENIER, J.; ADOU-BRYN, K.D.; DOUCHET, C. et al. - In vitro activity of amphotericin B, fluconazole and voriconazole against 162 Cryptococcus neoformans isolates from Africa and Cambodia, Europ. J. clin. Microbiol. infect Dis., 23: 506-508, 2004.
3. CHEN, S.; SORRELL, T.; NIMMO, G. et al. - Epidemiology and host- and variety-dependent characteristics of infection due to Cryplococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group. Clin. infect. Dis., 31: 499-508, 2000.
4. DATTA, K.; JAIN, N.; SETHI, S. et al. - Ruconazole and itraconazole susceptibility of clinical isolates of Cryptococcus neoformans at a tertiary care centre in India: a need for care. J. Antimicrob. Chemother., 52: 683-686, 2003.
5. ELLIS, D. & PFEIFFER, T.J - Natural habitat of Cryptococcus neoformans var. gattii. J. clin Microbiol., 28: 1642-1644, 1990.
6. FERNANDES, O.F.L.; COSTA, T.R.; COSTA M.R. et al. - Cryptococcus neoformans isolados de pacientes com AIDS. Rev. Soc. bras. Med. trop., 33: 75-78, 2000.
7. FRANZOT, S.P. & HAMDAN, J.S. - In vitro susceptibilities of clinical and environmental isolates of Cryptococcus neoformans to five antifungal drugs. Antimicrob. Agents Chemother., 40: 822-824, 1996.
8. GUIMARÃES, M.D.C. - Estudo temporal das doenças associadas à AIDS no Brasil, 1980-1999. Cad. Saúde públ. (Rio de J.), 16 (suppl. 1): 21-36, 2000.
9. HORTA, J.A.; STAATS, C.C.; CASALI, A.K. et al. - Epidemiological aspects of clinical and environmental Cryptococcus neoformans isolates in Brazilian State Rio Grande do Sul. Med. Mycol., 40: 565-571, 2002.
10. KURTZMAN, C.P. & FELL, J.W. - The yeasts, a taxonomic study. 4. ed. Amsterdam, Elsevier, 1998.
11. KWONG-CHUNG, K.J. - Cryptococcus neoformans. In: KWONG-CHUNG, K.J. & BENNETT, J.E. Medical Mycology. Philadelphia, Lea & Febiger, 1992. p. 397-466.
12. KWONG CHUNG, K.J.; POLACHECK, I. & BENNETT, J.E. - Improved diagnostic medium for separation of Cryptococcus neaformans var. neoformans (serotypes A and D) and Cryptococcus neoformans var. gaitii (serotypes B and C). J. clin. Microbiol., 15: 535-537, 1982.
13. LICEA, B.A.; GARZA, D.G.; URBIETA, V.F. & OLIVARES, R.A.C. - Aislamiento y caracterización de Cryptococcus neoformans var. gattii a partir de muestras de Eucalyptus camaldulensis en la ciudad de México. Rev. iberoamer. Micol., 16: 40-42, 1999.
14. LOZANO-CHIU, M.; PAETZNICK, V.L.; GHANNOUM, M.A. & REX, J.H. - Detection of resistance to amphotericin B among Cryptococcus neoformans clinical isolates: performances of three different media assessed by using E-test and National Committee for Clinical Laboratory Standards M27-A methodologies. J. clin. Microbiol., 36: 2817-2822, 1998.
15. MAXWELL, M.J.; MESSER, S.A.; HOLLIS, R.J.; DIEKEMA, D.J. & PFALLER, M.A. - Evaluation of Etest method for determining voriconazole and amphotericin B MICs for 162 clinical isolates of Cryptococcus neoformans. J. clin. Microbiol., 41: 97-99, 2003.
16. MONTENEGRO, H. & PAULA, C.R. - Environmental isolation of Cryptococcus neoformans var. gattii and Cryptococcus neoformans var. neoformans in the city of São Paulo, Brazil. Med. Mycol., 38: 385-390, 2000.
17. MONDON, P.; PETTER, R.; AMALFITANO, G. et al. - Heteroresistance to fluconazole and voriconazole in Cryptococcus neoformans. Antimicrob. Agents Chemother., 43: 1856-1861, 1999.
18. MORAES, E.M.; PRÍMOLA, N.S. & HAMDAN, J.S. - Antifungal susceptibility of clinical and environmental isolates of Cryptococcus neoformans to four antifungal drugs determined by two techniques. Mycoses, 46: 164-168, 2003.
19. NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS - Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard. Villanova, NCCLS, 2002. v. 17, No. 9. (Document M27-A2).
20. NGUYEN, M.H. & YU, C.Y. - In vitro comparative efficacy of voriconazole and itraconazole against fluconazole-susceptible and -resistant Cryptococcus neoformans isolates. Antimicrob. Agents Chemother., 42: 471-472, 1998.
21. NISHIKAWA, M.M.; LAZERA, M.S.; BARBOSA, G.G. et al. - Serotyping of 467 Cryptococcus neoformans isolates from clinical and environmental sources in Brazil: analysis of host and regional patterns. J. clin. Microbiol., 41: 73-77, 2003.
22. OHKUSU, M.; TANGONAN, N.; TAKEO, K. et al. - Serotype, mating type and ploidy of Cryptococcus neoformans strains isolated from patients in Brazil. Rev. Inst. Med. trop. S. Paulo, 44: 299-302, 2002.
23. PFALLER, M.A.; ZHANG, J. & MESSER, S.A. - In vitro activities of voriconazole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa. Antimicrob. Agents Chemother., 43: 169-171, 1999.
24. SOARES, M.C.B.; PAULA, C.R.; DIAS, A.L.T.; CASEIRO, M.M. & COSTA, S.O.P. - Environmental strains of Cryptococcus neoformans variety grubii in the city of Santos, SP, Brazil. Rev. Inst. Med. trop. S.Paulo, 47: 31-36, 2005.
25. SORRELL, T.C. - Cryptococcus neoformans variety gattii. Med. Mycol., 39: 155-168, 2001.
26. STEENBERGEN, J.N. & CASADEVALL, A. - The origin and maintenance of virulence for the human pathogenic fungus Cryptococcus neoformans. Microbes Infect., 5: 667-675, 2003.
27. TAYLOR, M.B.; CHADWICK, D. & BARKHAM, T. - First reported isolation of C. neoformans var. gattii from a patient in Singapore. J. clin. Microbiol., 40: 3098-3099, 2002.